CareDx (CDNA) director sells 44,700 shares, still holds direct and trust stake

Rhea-AI Filing Summary

CareDx, Inc. director Michael Goldberg reported selling 44,700 shares of Common Stock on August 4, 2026 at an average price of $47.0581 per share. After the sale he holds 61,738 shares directly and 91,045 shares indirectly through the Cavallo Trust, where he and his spouse are trustees.

Insider Trade Summary

Net Seller: 44,700 shares

Net Sell 2 txns

Insider Goldberg Michael

Role Director

Sold 44,700 shs ($2.10M)

Type	Security	Shares	Price	Value
Sale	Common Stock	44,700	$47.0581	$2.10M
holding	Common Stock F1	--	--	--

Holdings After Transaction: Common Stock — 61,738 shares (Direct); Common Stock — 91,045 shares (Indirect, See Footnote)

Footnotes (1)

1. F1. Represents shares held by the Cavallo Trust of which the Reporting Person and the Reporting Person's spouse are trustees.

Key Figures

Shares sold: 44,700 shares Average sale price: $47.0581 per share Direct holdings after sale: 61,738 shares +1 more

4 metrics

Shares sold 44,700 shares Common Stock sale reported on August 4, 2026

Average sale price $47.0581 per share Price per share for the 44,700-share Common Stock sale

Direct holdings after sale 61,738 shares Common Stock held directly by Michael Goldberg following the sale

Indirect trust holdings 91,045 shares Shares held indirectly through the Cavallo Trust

Key Terms

Cavallo Trust, nature of ownership, open market or private transaction

3 terms

Cavallo Trust financial

"Represents shares held by the Cavallo Trust of which the Reporting Person"

nature of ownership financial

""nature_of_ownership": "See Footnote""

open market or private transaction financial

"Sale in open market or private transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/06/2026 - 04:06 PM Accepted by SEC EDGAR 08/06/2026 - 04:05 PM Learn about SEC filing dates

FAQ

What transaction did CareDx (CDNA) director Michael Goldberg report?

Michael Goldberg reported a sale of 44,700 shares of CareDx Common Stock on August 4, 2026 at an average price of $47.0581 per share. The transaction is classified as a sale in an open market or private transaction.

How many CareDx (CDNA) shares did Michael Goldberg sell and at what price?

Michael Goldberg sold 44,700 shares of CareDx Common Stock at an average price of $47.0581 per share. This sale is reported as a non-derivative transaction coded as a sale in an open market or private transaction.

What are Michael Goldberg’s remaining direct CareDx (CDNA) holdings after the sale?

Following the reported sale, Michael Goldberg directly holds 61,738 shares of CareDx Common Stock. This figure reflects his direct ownership position immediately after the August 4, 2026 transaction disclosed in the insider report.

Does Michael Goldberg report any indirect CareDx (CDNA) share ownership?

Yes. Michael Goldberg reports 91,045 shares held indirectly through the Cavallo Trust. He and his spouse are trustees of this trust, and the shares attributed to it are reported as his indirect ownership interest in CareDx.

Was Michael Goldberg’s CareDx (CDNA) stock sale under a Rule 10b5-1 trading plan?

The transaction is not marked as being pursuant to a Rule 10b5-1 trading plan. The Form 4’s Rule 10b5-1 checkbox is not checked, and no accompanying footnote describes the sale as occurring under a pre-arranged trading plan.

What type of transaction code is used for Michael Goldberg’s CareDx (CDNA) sale?

The sale is reported with transaction code “S”, described as a “Sale in open market or private transaction.” This indicates a non-derivative sale of Common Stock rather than an option exercise or derivative-related transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldberg Michael

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BOULEVARD, 4TH FLOOR

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2026		S		44,700	D	$47.0581	61,738	D
Common Stock								91,045	I	See Footnote(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares held by the Cavallo Trust of which the Reporting Person and the Reporting Person's spouse are trustees.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)